Core Viewpoint - The stock price of Boyuan Co., Ltd. has increased by 5.22% on November 14, reaching 93.30 CNY per share, with a total market capitalization of 12.469 billion CNY, indicating a continuous upward trend over the past three days with a cumulative increase of 5.45% [1] Company Overview - Boyuan Co., Ltd. is located in Shouguang City, Shandong Province, and was established on August 6, 2008. The company specializes in the research, production, and sales of fine chemicals, including organic iodides, inorganic iodides, precious metal catalysts, luminescent materials, and hexamethyldisilazane. It also engages in the recycling of iodine and precious metal materials [1] - The main revenue composition of Boyuan Co., Ltd. includes iodides (74.56%), specialty functional chemicals (12.79%), trading business (9.94%), and others (2.72%) [1] Shareholder Information - Among the top ten circulating shareholders of Boyuan Co., Ltd., a fund under AVIC Fund ranks as a significant holder. The AVIC New Start Flexible Allocation Mixed A Fund (005537) entered the top ten shareholders in the third quarter, holding 1.3456 million shares, which accounts for 4.03% of the circulating shares. The estimated floating profit today is approximately 6.2304 million CNY [2] - During the three-day increase, the floating profit earned was 616.31 thousand CNY [2] Fund Manager Profile - The fund manager of AVIC New Start Flexible Allocation Mixed A Fund (005537) is Han Hao, who has been in the position for 7 years and 338 days. The total asset size of the fund is 15.589 billion CNY, with the best fund return during his tenure being 205.01% and the worst being -18.95% [3]

Core Insights - On November 12, Boyuan Co., Ltd. saw a stock increase of 1.35% with a trading volume of 211 million yuan [1] - The company reported a net financing purchase of 7.72 million yuan on the same day, with a total financing balance of 175 million yuan, accounting for 6.06% of its market capitalization [1][2] Company Overview - Boyuan Co., Ltd. is located in Shouguang City, Shandong Province, and was established on August 6, 2008, with a planned listing date of December 11, 2024 [2] - The company specializes in the research, production, and sales of fine chemicals, including organic iodides, inorganic iodides, precious metal catalysts, luminescent materials, and hexamethyldisilazane [2] - The revenue composition includes iodides (74.56%), specialty functional chemicals (12.79%), trading business (9.94%), and others (2.72%) [2] Financial Performance - For the period from January to September 2025, Boyuan Co., Ltd. achieved a revenue of 1.073 billion yuan, representing a year-on-year growth of 6.60% [2] - The net profit attributable to shareholders was 132 million yuan, showing a year-on-year decrease of 22.53% [2] Shareholder Information - As of November 10, 2025, the number of shareholders for Boyuan Co., Ltd. was 11,900, a decrease of 12.88% from the previous period [2] - The average circulating shares per person increased by 14.78% to 2,813 shares [2] - The company has distributed a total of 88.408 million yuan in dividends since its A-share listing [3] Institutional Holdings - As of September 30, 2025, several new institutional shareholders have entered, including: - China Aviation New Start Flexible Allocation Mixed A (005537) as the second-largest shareholder with 1.3456 million shares [3] - Hong Kong Central Clearing Limited as the third-largest shareholder with 964,400 shares [3] - Other new shareholders include Yongying New Materials and Penghua Huizhi [3]

Core Insights - The company reported that as of November 10, 2025, the total number of shareholders is 11,873 [2] Summary by Category - **Shareholder Information** - The total number of shareholders for the company is 11,873 as of the specified date [2]

Group 1 - The core point of the article is that Boyuan Co., Ltd. (301617) has confirmed its iodine methyl product capacity to be 200 tons per year [1]

Group 1 - The core viewpoint of the article is that Boyuan Co., Ltd. has achieved large-scale sales of electronic-grade potassium iodide, primarily used in the polarizer industry [1] - The company currently does not have any products in mass production for direct application in the semiconductor field [1]

Core Viewpoint - The company, Boyuan Co., primarily produces fine chemicals that are widely used in various sectors including pharmaceuticals, chemicals, optoelectronic materials, feed, and food [1] Group 1 - The main products of the company are fine chemicals [1] - The applications of the products span across multiple industries [1]

Group 1 - The company stated that information regarding its lithium iodide product partners is considered a trade secret and cannot be disclosed publicly [1] - Product pricing is adjusted based on market supply and demand factors, following industry practices [1]

Core Viewpoint - 博苑股份 has seen a significant decrease in the number of shareholders, indicating a potential shift in investor sentiment and market dynamics [1] Shareholder Information - As of November 10, the number of shareholders for 博苑股份 was 11,873, a decrease of 1,755 from the previous period (October 31), representing a decline of 12.88% [1] Stock Performance - The closing price of 博苑股份 on the reporting date was 86.25 yuan, reflecting an increase of 1.35%. However, since the beginning of the current concentration period, the stock price has cumulatively decreased by 5.93%, with 4 days of increases and 4 days of decreases [1] Margin Trading Data - The latest margin trading balance for 博苑股份 as of November 11 was 167 million yuan, with the financing balance also at 167 million yuan. During the current concentration period, the financing balance has decreased by 34.0651 million yuan, a decline of 16.95% [1] Financial Performance - According to the third-quarter report, 博苑股份 achieved a total operating revenue of 1.073 billion yuan in the first three quarters, representing a year-on-year growth of 6.60%. However, net profit was 132 million yuan, showing a year-on-year decline of 22.41%. The basic earnings per share were 0.9912 yuan, and the weighted average return on equity was 7.93% [1]

Group 1 - The core viewpoint of the news is that Boyuan Co., Ltd. (SZ 301617) is actively engaging with investors, indicating a focus on transparency and communication regarding its business operations [1] - Boyuan Co., Ltd. will participate in an investor research meeting on November 12, 2025, with key executives including the Executive Vice President, Secretary of the Board, Chief Financial Officer, and Securities Affairs Representative present to address investor inquiries [1] - As of the latest report, Boyuan Co., Ltd. has a market capitalization of 11.5 billion yuan [3] Group 2 - For the year 2024, Boyuan Co., Ltd. reports that its revenue composition is entirely from the chemical industry, indicating a focused business model [2]

Market Outlook - The market for inorganic iodides is expected to grow significantly due to increasing medical expenditures driven by rising living standards, aging populations, and heightened health awareness [2][3] - The demand for contrast agents in the diagnosis of diseases such as tumors, cardiovascular diseases, and neurological disorders is projected to steadily increase, expanding the domestic contrast agent market [2][3] - The rapid development of the global pharmaceutical industry, particularly in new drug research and development, is expected to further drive the demand for high-quality pharmaceutical intermediates [3] Production Capacity Expansion - The company is establishing a new production project for 4,000 tons/year of inorganic iodides to enhance capacity and diversify its product offerings, focusing on high-value products for pharmaceutical and electronic applications [4] Competitive Advantages - **Resource Recycling and Service Integration**: The company has developed a unique "iodine resource recycling" industry chain, reducing reliance on imported iodine and lowering procurement costs while providing integrated solutions to clients [4] - **Regulatory Compliance and Scale**: As a leading iodine resource utilization enterprise, the company has a robust capacity for iodine recycling and complies with environmental regulations, enhancing collaboration with clients [4][5] - **Technological Innovation**: The company emphasizes continuous technological advancement and has established a comprehensive R&D and talent incentive system, leading to industry-leading processes and patented technologies [5] - **Quality Control and Client Relationships**: A thorough quality control system ensures product quality, with core products certified by authoritative bodies, fostering long-term trust with major clients [5] Shareholder Information - The company plans to release 19,630,000 shares from lock-up on December 11, 2025, with no current plans for shareholder reductions communicated [5]